Results 241 to 250 of about 68,398 (251)

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases

Journal of Hepatology, 2000
Filomena Conti, François Durand, Yvon Calmus   +2 more
exaly  

A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies

Advances in Therapy, 2016
Christian Klein, , Gunter Fingerle-Rowson   +2 more
exaly  

HUMANIZED ANTI-CD20 MONOCLONAL ANTIBODY

2007
UCHIYAMA SUSUMU, FUKUI KIICHI
openaire   +2 more sources

Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

2009
Olaf Weingart, Thomas Elter, Kathrin Bauer, Corinne Brillant, Christine Herbst, Ina Monsef, Nicole Skoetz, Andreas Engert   +7 more
openaire   +1 more source

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study

European Journal of Haematology, 2002
exaly  

Humanized anti-CD20 monoclonal antibody

2015
LIU JIE, ZHANG YONGKE
openaire   +1 more source

Ofatumumab, the first human anti‐CD20 monoclonal antibody for the treatment of B cell hematologic malignancies

Annals of the New York Academy of Sciences, 2012
exaly  

Anti-CD20/CD3 Bispecific Monoclonal Antibody RO7082859

2020
openaire   +1 more source

Anti-CD20 monoclonal antibody-related eye disorders

Reactions Weekly
openaire   +1 more source

Anti-CD20-monoclonal-antibody/dexamethasone/polatuzumab-vedotin

Reactions Weekly
openaire   +1 more source